Background
==========

The World Health Organization (WHO) defines pharmacovigilance as "the science and activities relating to the detection, assessment, understanding and prevention of adverse effects or any other possible drug-related problems".[@b1-tcrm-13-1175] Pharmacovigilance is essential for the safe, rational, as well as cost-effective utilization of medicines worldwide; it plays an important role in improving the clinical outcomes and also decreasing mortality and morbidity rates.[@b2-tcrm-13-1175] The success of pharmacovigilance centres depend on the rate of effective and spontaneous reporting of suspected adverse drug reactions (ADRs), as is considered the core component of pharmacovigilance activities.[@b3-tcrm-13-1175]--[@b5-tcrm-13-1175] ADRs is defined by WHO as "any noxious, unintended, and undesired effect of drug that occurs as a result of treatment with drug at normal doses used in man for diagnosis, prophylaxis, and treatment".[@b6-tcrm-13-1175] ADRs are considered a major cause of patients' morbidity, mortality, hospital admissions, as well as increasing length of hospitalization and cost of treatment.[@b6-tcrm-13-1175] Literature demonstrates the importance of involving pharmacists in ADR reporting and considered pharmacists the most valuable sources of spontaneous reporting of ADRs.[@b7-tcrm-13-1175]--[@b9-tcrm-13-1175]

Community pharmacies in Yemen are considered as the most accessible and affordable health care facility to patients. This gives both licensed community pharmacists (BPharm holders) and pharmacy technicians working under the pharmacists supervision (diploma holders) the opportunity to detect and report ADRs more than any other health care professional.[@b10-tcrm-13-1175],[@b11-tcrm-13-1175] The Yemeni Pharmacovigilance Centre in Yemen was established in the capital, Sana'a, in early 2011 serving as a national centre to collect, compile and analyze data on ADRs; identification of risk factors and possible mechanisms underlying adverse reactions; as well as drug quality surveillance.[@b12-tcrm-13-1175]

Underreporting is considered one of the major challenges of the Yemeni Pharmacovigilance Centre. ADR knowledge among health care professionals is one of the major factors affecting ADRs reporting. Pharmacists, as well as other health care professionals, cannot participate effectively in ADR reporting without sufficient knowledge of ADRs and ADR reporting process. Literature review shows that health care professionals, including pharmacists, have a poor knowledge regarding pharmacovigilance.[@b13-tcrm-13-1175],[@b14-tcrm-13-1175] There is a lack of studies about knowledge and attitude of community pharmacy technicians toward pharmacovigilance and ADR reporting in Yemen. Therefore, the aim of this study was to assess the knowledge, attitude and barriers of community pharmacists, as well as pharmacy technicians, toward pharmacovigilance, and ADR reporting in Yemen.

Methods
=======

A cross-sectional study was conducted over a period of 3 months among community pharmacists and pharmacy technicians in Sana'a, Yemen.

Sample size
-----------

According to the annual reports of the Ministry of Public Health and Population 2011, there were 1,160 community pharmacies in the capital, Sana'a.[@b14-tcrm-13-1175],[@b15-tcrm-13-1175] Based on this report, a random sample of 289 community pharmacies were selected, this was to have an estimate of precision at a 95% confidence interval (CI), with α=0.05.

Study tools
-----------

This cross-sectional survey was conducted using a self-administered questionnaire given face-to-face by the researchers. The questionnaire was developed and validated based on the information from literature.[@b16-tcrm-13-1175]--[@b18-tcrm-13-1175]

The questionnaire was pilot tested on a convenience sample of 6 pharmacists and 4 pharmacy technicians to test the validity of the questionnaire. The final questionnaire comprised of six sections. Section one included the demographic characteristics of respondents, qualifications and experience. Section two included ten open ended questions to evaluate the knowledge of the participants toward pharmacovigilance, ADRs and ADR reporting. Section three contained two questions exploring the experience of participants with ADRs and its reporting. Section four was looking at the attitude of participants toward pharmacovigilance and ADR reporting. Section five looked at determining the barriers of reporting ADRs. Section six aimed at exploring the factors that would encourage community pharmacy technicians in Yemen to report ADRs.

A score of 1 and 0 was given for each correct or incorrect answer, respectively, the total score for each participant was the summation of the scores in each section. In the knowledge section, scores could range from zero to ten and were trichotomized into three levels: good knowledge (score ≥7), moderate knowledge (score 5--6), and poor knowledge (score ≤4). Regarding attitudes, barriers, and factors that encourage ADRs reporting, a 4-point Likert scale was used (A: agree; SA: strongly agree; D: disagree; and SD: strongly disagree).

The attitude evaluation had a maximum score of 13. A score of 1 and 0 was given for each positive (strongly agree, agree) or negative answer (disagree, strongly disagree), respectively. Total scores were calculated for each participant. A total score \>7 was considered as a positive attitude, a score ≤7 were considered as a negative attitude.

All community pharmacy technicians without an appropriate certification or diploma in pharmacy were excluded from this study.

Ethical approval
----------------

This study was approved by the Ethics Committee of University of Science and Technology, Yemen, and also by the managers of the enrolled community pharmacies. Furthermore, all respondents were fully informed and gave their written informed consent before participating in the study.

Statistical analysis
--------------------

Demographic variables and experiences of participants included in the study were examined on a descriptive basis. Percentages and frequencies were used for the categorical variables, while mean and standard deviation were calculated for the continuous variables. To examine for differences between pharmacists and pharmacy technicians in terms of knowledge, attitude and barriers to ADRs reporting, a Student's *t*-test was used to compare continuous variables, whereas a Pearson's chi square test/Fisher's exact test was used to compare categorical variables. All analyses were performed using SPSS statistical software version 18 (SPSS Inc., Chicago, IL, USA). *P*-values \<0.05 was considered to indicate statistical significance.

Results
=======

A total of 428 community pharmacists and pharmacy technicians were contacted, with 179 completing the questionnaire. Of the 179 respondents, 21 (11.7%) were pharmacists and 158 (88.3%) were pharmacy technicians, of which 176 (98.3%) were male and 3 (1.7%) were female. One-hundred-and-seventy-seven respondents (98.9%) had graduated in Yemen. The mean age of the respondents was 25.87±2.63 years. A majority of the respondents (108 \[60.3%\]) had ≤3 years work experience while 71 respondents (39.7%) had \>3 years work experience.

Knowledge about pharmacovigilance, ADRs and ADR reporting in Yemen
------------------------------------------------------------------

Findings of this study showed significant differences between the pharmacists and pharmacy technicians in terms of understanding the concept and importance of pharmacovigilance, ADRs and its type, the difference between ADRs and side effects, who should report ADRs, the reporting procedures, establishment year, and the location of the Pharmacovigilance Centre in Yemen (*P*\<0.05). The pharmacists answered the knowledge related questions better than pharmacy technicians. There was no significant difference between pharmacists and pharmacy technicians with regard to the question "What is the objectives of the Pharmacovigilance Centre in Yemen?" (*P*=0.117), with only one pharmacist answering this question correctly. There was a significant difference between the pharmacists and pharmacy technicians in terms of knowledge total scores (*P*\<0.05). The mean knowledge scores for pharmacists was 3.33±2.852 compared to 0.15±0.666 for pharmacy technicians. There was a significant difference between the pharmacists and pharmacy technicians in terms of good knowledge (*P*\<0.05). Five pharmacists (23.8%) had good knowledge, while two (1.3%) pharmacy technicians had moderate knowledge, and 98.7% had poor knowledge. [Table 1](#t1-tcrm-13-1175){ref-type="table"} shows the comparison between pharmacists and pharmacy technicians in terms of knowledge related questions.

ADR reporting experience among community pharmacists and pharmacy technicians in Yemen
--------------------------------------------------------------------------------------

The findings of this study showed that no pharmacy technicians and only nine pharmacists (42.9%) had observed ADRs in their practice. The most common ADRs they detected were allergy and diarrhea. However, no ADRs were reported.

Attitude of community pharmacy technicians in Yemen toward pharmacovigilance and ADRs reporting
-----------------------------------------------------------------------------------------------

The findings of this study showed no significant difference between the pharmacists and pharmacy technicians in terms of attitude toward the question "I believe that pharmacovigilance is important" (*P*=0.11). The majority of pharmacists (61.9%) believed that pharmacovigilance is important, while only 43% pharmacy technicians believed that pharmacovigilance is important. There was a significant difference between pharmacists and pharmacy technicians in terms of believing that reporting ADRs is part of their professional duties (*P*\<0.05). The majority of pharmacists (76.2%) felt that reporting ADRs was part of their professional duties compared to only 27.2% of pharmacy technicians. There was no significant difference between the pharmacists and pharmacy technicians in terms of attitude toward the question "I have to be sure the ADR is related to the drug before reporting" (*P*=0.14). There was a significant difference between the pharmacists and pharmacy technicians in terms of attitude toward reporting ADRs related to over the counter products (*P*\<0.05). Only five pharmacists (23.8%) said that they would report an event, while only two pharmacy technicians (1.3%) said that they would report it. There were no significant differences between pharmacists and pharmacy technicians in terms of attitude toward reporting ADRs that caused hospitalization, life-threatening situations, a congenital anomaly, persistent disability or incapacity, or death (*P*=1.00).

The majority of pharmacists, as well as pharmacy technicians, said that they would report these ADRs. There was a significant difference (*P*\<0.05) between pharmacists and pharmacy technicians in terms of attitude toward the following questions: "I report to get more insight into ADR questions that I come across in my practice"; "I report to show the patient that their concern is being taken seriously"; "I always report ADRs because it is part of pharmaceutical care" and "Consulting the physician is important before reporting an ADR". Generally, pharmacists showed better attitudes toward the above four mentioned questions than pharmacy technicians. There was a significant difference between the pharmacists and pharmacy technicians in terms of attitude total scores (*P*\<0.05). There was a significant difference between pharmacists attitude mean score (9.62±2.50) and pharmacy technicians attitude mean score (6.56±1.79) (*P*\<0.05). All pharmacists had a positive attitude while only 68 (43%) of pharmacy technicians had a positive attitude toward pharmacovigilance and ADR reporting. [Table 2](#t2-tcrm-13-1175){ref-type="table"} shows the comparison between pharmacists and pharmacy technicians in terms of attitude related questions.

Association between good knowledge and positive attitude
--------------------------------------------------------

The findings of this study showed that there was a significant association (*P*\<0.05) between good knowledge and a positive attitude toward reporting ADRs.

Barriers of ADR reporting
-------------------------

There was a significant difference between pharmacists and pharmacy technicians in terms of reported barriers in this study ([Table 3](#t3-tcrm-13-1175){ref-type="table"}). The most commonly given reasons for not reporting ADRs by community pharmacists were: "I don't report because I find it difficult to admit that the patient has been harmed" (100%); "I don't report because reporting may give the impression that I am ignorant concerning ADRs" (100%) and "All serious ADRs are detected before registration" (76.2%). The most commonly given reasons for not reporting ADRs by pharmacy technicians were reported: "All serious ADRs are detected before registration" (99.4%); "Reporting ADRs is time consuming" (98.9%); "I don't report ADR because reporting forms are not available" (92.4%); "I don't report because I have insufficient clinical knowledge" (80.4%) and "I don't report ADRs because I don't know the address where these reports should be sent" (92.4%). [Table 3](#t3-tcrm-13-1175){ref-type="table"} shows the comparison between pharmacists and pharmacy technicians in terms of barriers related questions.

Factors encouraging ADR reporting
---------------------------------

The findings of this study showed that the factors to encourage ADRs reporting were attending course or workshops, educational materials, more attention to ADR reporting in pharmacy curriculum, simplification of reporting procedure, and promoting reporting as a part of professional duty. [Table 4](#t4-tcrm-13-1175){ref-type="table"} shows the comparison between pharmacists and pharmacy technicians in terms of factors encouraging ADRs reporting questions.

Discussion
==========

This study aimed to investigate the knowledge, attitude and barriers of both community pharmacists and pharmacy technicians toward pharmacovigilance, ADRs and ADR reporting in Yemen. This issue is very important to research in order to identify the required interventions so that the spontaneous ADR reporting can be improved, as both pharmacists and pharmacy technicians cannot participate effectively in ADR reporting without sufficient knowledge about pharmacovigilance and reporting process.

The concept of pharmacovigilance in Yemen is relatively new as until recently there was only a minimum exposure given during the training of pharmacy or medical students. The national Yemeni Pharmacovigilance Centre was only established in early 2011, which is considered late in comparison to other countries in the region. Few studies have investigated the knowledge, attitude and practice of community pharmacists toward ADRs and its reporting in Arabic countries, with none of these studies in Yemen.[@b7-tcrm-13-1175],[@b19-tcrm-13-1175],[@b20-tcrm-13-1175]

The results of this study show that the majority of community pharmacies in Yemen is run by pharmacy technicians (88.7%), which is consistent with previous reports.[@b10-tcrm-13-1175],[@b11-tcrm-13-1175] These reports state that pharmacy practice in Yemen faces major challenges to move toward providing better pharmaceutical care due to a number of reasons including that the number of pharmacists working in community pharmacies is insuffiecent.[@b10-tcrm-13-1175],[@b11-tcrm-13-1175] The results of these studies show that the majority of pharmacists and pharmacy technicians in Yemeni community pharmacies were male (98.3%), which is similar to a previous study,[@b21-tcrm-13-1175] and could be due to the fact that 70% of pharmacy students in Yemen are males.

Knowledge about pharmacovigilance, ADRs and ADR reporting in Yemen
------------------------------------------------------------------

Only five pharmacists (23.8%) had a good knowledge toward pharmacovigilance, ADRs and ADR reporting, while no pharmacy technicians met the "good knowledge" criteria. This is a similar finding with studies from other Arabic countries in terms of poor knowledge among pharmacists.[@b19-tcrm-13-1175],[@b20-tcrm-13-1175],[@b22-tcrm-13-1175]--[@b24-tcrm-13-1175] However, the current study differs from these other studies in design and sample size. This study also included mixed qualitative and quantitative analysis along with including pharmacy technicians due to the nature of the pharmacy practice in Yemeni community pharmacies being different from other Arabic countries.[@b10-tcrm-13-1175]

Experience of community pharmacy technicians in Yemen with ADRs and its reporting
---------------------------------------------------------------------------------

The findings of this study showed that there were only nine pharmacists (42.9%) who observed ADRs in their practice. The most common ADRs they detected were allergy and diarrhea. However, they did not report these ADRs. This finding is different from studies undertaken in other Arabic countries[@b19-tcrm-13-1175],[@b20-tcrm-13-1175],[@b22-tcrm-13-1175]--[@b24-tcrm-13-1175] in terms of reporting ADRs. This could be due to the Yemeni Pharmacovigilance Centre only being established in Sana'a early 2011 which has faced challenges in reporting and marketing its activities.[@b12-tcrm-13-1175]

Attitude of community pharmacy technicians in Yemen toward pharmacovigilance and ADRs reporting
-----------------------------------------------------------------------------------------------

There was a significant difference between pharmacists and pharmacy technicians in terms of positive attitude toward pharmacovigilance (*P*\<0.05). All pharmacists had a positive attitude while only 68 (43%) pharmacy technicians had a positive attitude toward pharmacovigilance and ADR reporting. This was due to the difference in knowledge between pharmacists and pharmacy technicians. As expected, the finding of this study showed a significant association (*P*\<0.05) between good knowledge and positive attitude toward reporting ADRs. This finding is in line with that of a study conducted in Saudi Arabia by Bawazir in terms of attitude of community pharmacists toward ADR reporting by pharmacists.[@b22-tcrm-13-1175] A difference in attitude between pharmacy technicians in Yemen and community pharmacists reported by Bawazir in Saudi Arabia[@b22-tcrm-13-1175] was observed, possibly due to the nature of pharmacy practice in community pharmacies being different.

Encouraging ADR reporting
-------------------------

Similar to other countries,[@b22-tcrm-13-1175]--[@b24-tcrm-13-1175] this study provides strong evidence of ADR under-reporting in Yemen. More efforts should be taken by the Pharmacovigilance Centre in Yemen to improve the awareness of health care professionals on benefits and risk of medicines, and thus, practice rational prescription of drugs and implement ADR reporting. In addition, patients should also be equipped with better knowledge of the consequences of drug use, and thus, using drugs more appropriately. ADR reporting can be promoted in many ways, such as distributing manuals on ADR reporting to all medical practitioners and pharmacists. ADR reporting forms with prepaid postage could be given free to doctors and pharmacists or online reporting system could be implemented. Educational talks, bulletins and annual-reports on ADRs could be distributed to public and private sector doctors and pharmacists.

Limitations of the study
------------------------

The current study has several limitations. This study was conducted in the capital, Sana'a, only, therefore the findings cannot be generalized to all Yemeni community pharmacists and pharmacy technicians. Another limitation is the small sample size of pharmacists included in this study. This is an intrinsic problem because of gross shortage of pharmacists in Yemen.

Conclusion
==========

Pharmacists have significantly better knowledge than pharmacy technicians with regard to pharmacovigilance. More than half of pharmacy technicians also showed a negative attitude toward ADR reporting. Therefore, educational interventions and training is very important for community pharmacists and pharmacy technicians in Yemen to increase their awareness and participation in ADR reporting.
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###### 

Comparison between pharmacists and pharmacy technicians in terms of knowledge related questions

  Knowledge questions                                                Pharmacists (N=21), n (%)   Pharmacy technicians (N=158), n (%)   *P*-value[\*](#tfn1-tcrm-13-1175){ref-type="table-fn"}
  ------------------------------------------------------------------ --------------------------- ------------------------------------- --------------------------------------------------------
  What is pharmacovigilance?                                         5 (23.8)                    2 (1.3)                               0.001[\*](#tfn1-tcrm-13-1175){ref-type="table-fn"}
  What is ADRs?                                                      12 (57.1)                   2 (1.3)                               0.001[\*](#tfn1-tcrm-13-1175){ref-type="table-fn"}
  How does an ADR differ from a side effect?                         12 (57.1)                   2 (1.3)                               0.001[\*](#tfn1-tcrm-13-1175){ref-type="table-fn"}
  What are the types of ADRs?                                        5 (23.8)                    0 (0)                                 0.001[\*](#tfn1-tcrm-13-1175){ref-type="table-fn"}
  Why is pharmacovigilance important?                                5 (23.8)                    1 (0.6)                               0.001[\*](#tfn1-tcrm-13-1175){ref-type="table-fn"}
  Who should report ADRs?                                            21 (100)                    14 (8.9)                              0.001[\*](#tfn1-tcrm-13-1175){ref-type="table-fn"}
  How should a report on ADRs be done?                               5 (23.8)                    2 (1.3)                               0.001[\*](#tfn1-tcrm-13-1175){ref-type="table-fn"}
  When was the Pharmacovigilance Centre in Yemen established?        2 (9.5)                     0 (0)                                 0.013[\*](#tfn1-tcrm-13-1175){ref-type="table-fn"}
  Where is the location of the Pharmacovigilance Centre in Yemen?    2 (9.5)                     0 (0)                                 0.013[\*](#tfn1-tcrm-13-1175){ref-type="table-fn"}
  What is the objectives of the Pharmacovigilance Centre in Yemen?   1 (4.8)                     0 (0)                                 0.117[\*](#tfn1-tcrm-13-1175){ref-type="table-fn"}
  Total score, mean ± SD                                             3.33±2.852                  0.15±0.666                            0.001[\*](#tfn1-tcrm-13-1175){ref-type="table-fn"}
  Good knowledge score                                               5 (23.8)                    0 (0)                                 0.001[\*](#tfn1-tcrm-13-1175){ref-type="table-fn"}

**Note:**

Chi-square test or Fisher's Exact test.

**Abbreviation:** ADRs, adverse drug reactions.

###### 

Comparison between pharmacists and pharmacy technicians in terms of attitude related questions

  Attitude questions                                                                      Pharmacists, (N=21), n (%)   Pharmacy technicians (N=158), n (%)   *P*-value
  --------------------------------------------------------------------------------------- ---------------------------- ------------------------------------- -------------------------------------------------------
  I believe that pharmacovigilance is important                                           13 (61.9)                    68 (43)                               0.110[\*](#tfn3-tcrm-13-1175){ref-type="table-fn"}
  Reporting ADRs is part of the professional duties of a pharmacist/pharmacy technician   16 (76.2)                    43 (27.2)                             \<0.05[\*](#tfn3-tcrm-13-1175){ref-type="table-fn"}
  I have to be sure the ADR is related to the drug before reporting                       21 (100)                     137 (86.7)                            0.140[\*](#tfn3-tcrm-13-1175){ref-type="table-fn"}
  I do not report ADRs of OTC products supplied by my pharmacy                            5 (23.8)                     2 (1.3)                               \<0.05[\*](#tfn3-tcrm-13-1175){ref-type="table-fn"}
  I report an ADR that causes:                                                                                                                               
   Hospitalization                                                                        21 (100)                     151 (95.6)                            1.000[\*](#tfn3-tcrm-13-1175){ref-type="table-fn"}
   A life-threatening situation                                                           21 (100)                     151 (95.6)                            1.000[\*](#tfn3-tcrm-13-1175){ref-type="table-fn"}
   A congenital anomaly                                                                   21 (100)                     151 (95.6)                            1.000[\*](#tfn3-tcrm-13-1175){ref-type="table-fn"}
   Persistent disability or incapacity                                                    21 (100)                     151 (95.6)                            1.000[\*](#tfn3-tcrm-13-1175){ref-type="table-fn"}
   Death of the patient                                                                   21 (100)                     151 (95.6)                            1.000[\*](#tfn3-tcrm-13-1175){ref-type="table-fn"}
  I report to get more insight into ADR questions that I come across in my practice       5 (23.8)                     4 (2.5)                               \<0.05[\*](#tfn3-tcrm-13-1175){ref-type="table-fn"}
  I report to show the patient that their concern is being taken seriously                5 (23.8)                     4 (2.5)                               \<0.05[\*](#tfn3-tcrm-13-1175){ref-type="table-fn"}
  I will report ADRs because it is part of pharmaceutical care                            16 (76.2)                    20 (12.7)                             \<0.05[\*](#tfn3-tcrm-13-1175){ref-type="table-fn"}
  Consulting the physician is important before reporting an ADR                           16 (76.2)                    3 (1.9)                               \<0.05[\*](#tfn3-tcrm-13-1175){ref-type="table-fn"}
  Total score, mean ± SD                                                                  9.62±2.500                   6.56±1.790                            \<0.05[\*\*](#tfn4-tcrm-13-1175){ref-type="table-fn"}
  Positive attitude score                                                                 21 (100)                     68 (43)                               \<0.05[\*](#tfn3-tcrm-13-1175){ref-type="table-fn"}

**Notes:**

Chi-square test or Fisher's Exact test;

Independent *t*-test.

**Abbreviations:** ADRs, adverse drug reactions; OTC, over the counter.

###### 

Comparison between pharmacists and pharmacy technicians in terms of barriers to ADR reporting questions

  Barrier to ADRs reporting questions                                                             Pharmacists (N=21), Agree; n (%)   Pharmacy technicians (N=158), Agree; n (%)
  ----------------------------------------------------------------------------------------------- ---------------------------------- --------------------------------------------
  I don't report ADRs because reporting form is not available                                     6 (28.6)                           146 (92.4)
  I don't report ADRs because I don't know the address where these reports should be sent         9 (42.9)                           146 (92.4)
  The reporting form is too complicated                                                           8 (38.1)                           125 (79.1)
  Reporting ADRs is time consuming                                                                8 (38.1)                           142 (98.9)
  All serious ADRs are detected before registration                                               16 (76.2)                          157 (99.4)
  I don't report ADRs because I want to publish about them myself                                 2 (9.5)                            158 (100)
  I don't report ADRs because I am not convinced about the confidential handling of the reports   2 (9.5)                            18 (11.4)
  I don't report ADRs because I fear it may harm the confidence of my patients                    3 (14.3)                           91 (57.6)
  I don't report because I find it difficult to admit that the patients have been harmed          21 (100)                           19 (12)
  I don't report because reporting may give the impression that I am ignorant concerning ADRs     21 (100)                           17 (10.8)
  I don't report because I fear legal liability for the reported ADRs                             4 (19)                             12 (7.6)
  I am not motivated to report                                                                    10 (47.6)                          132 (83.5)
  I don't report because I have insufficient clinical knowledge                                   3 (14.3)                           127 (80.4)
  I don't report because I don't know how to report ADRs                                          16 (76.2)                          147 (93)
  I don't report because I am not convinced the ADRs is caused by the drug                        8 (38.1)                           119 (75.3)

**Abbreviation:** ADRs, adverse drug reactions.

###### 

Comparison between pharmacists and pharmacy technicians in terms of factors that encourage ADRs reporting

  Factors encouraging ADR reporting                                      Pharmacists (N=21), Agree; n (%)   Pharmacy technicians (N=158), Agree; n (%)
  ---------------------------------------------------------------------- ---------------------------------- --------------------------------------------
  I will report if:                                                                                         
   I attended courses or workshops to understand the reporting process   21 (100)                           127 (80.4)
   I received materials to understand the reporting process              21 (100)                           127 (80.4)
   ADR reporting is taught in university                                 21 (100)                           158 (100)
   The reporting procedure is simplified                                 21 (100)                           124 (87.5)
   It is part of the professional duty                                   21 (100)                           158 (100)
   There is an incentive                                                 10 (47.6)                          132 (83.5)
   I receive more feedback through mailings                              13 (61.9)                          34 (21.5)
   It is a compulsory report                                             15 (71.4)                          57 (36.1)

**Abbreviation:** ADRs, adverse drug reactions.
